Please login to the form below

Not currently logged in
Email:
Password:

leukaemia

This page shows the latest leukaemia news and features for those working in and with pharma, biotech and healthcare.

MaxCyte gets green light for solid tumour cell therapy

MaxCyte gets green light for solid tumour cell therapy

only for haematologic cancers like leukaemia and lymphoma.

Latest news

More from news
Approximately 77 fully matching, plus 350 partially matching documents found.

Latest Intelligence

  • No incentive for a cure No incentive for a cure

    These include Kymriah, the pioneering CAR-T cell therapy from Novartis, which demonstrated a remarkable 83% remission rate in children and young adults with B-cell precursor acute lymphoblastic leukaemia.

  • Deal Watch January 2018

    leukaemia (ALL), Juno's share price had been in the low $20s for several months.

  • The tipping point The tipping point

    In 2016 alone, there were approximately 30 oncology drugs in late stage development for breast cancer, leukaemia, lung cancer and ovarian cancer.

  • Pharma deals continue to slide Pharma deals continue to slide

    This referred to the CAR-T therapy, Kymriah, from Novartis for treating a form of acute lymphoblastic leukaemia in children and young adults.

  • Attracting doctors to low-demand specialties Attracting doctors to low-demand specialties

    such as leukaemias, lymphomas and myelomas, while haemophilia warrants just one or two sessions.

More from intelligence
Approximately 1 fully matching, plus 40 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 13 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Clark Health Communications

Clark Health Communications (CHC) is an independent, award-winning health and medical communications agency. Our collaboration with experts and advocates enhances...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics